There is no single best treatment for dry eyes because the condition has multiple causes and the right approach depends on what is driving your symptoms. Someone whose tears evaporate too quickly because of clogged oil glands in the eyelids needs a different strategy than someone whose eyes simply do not produce enough tear fluid. For mild cases, preservative-free artificial tears and a few habit changes are often enough. For moderate to severe dry eye, the treatment landscape has expanded considerably in recent years, with prescription anti-inflammatory drops, in-office eyelid procedures, nasal sprays that stimulate natural tear production, and even specialized contact lenses all playing a role.
Why the Type of Dry Eye Matters
Dry eye disease generally falls into two overlapping categories. In one, the lacrimal glands do not produce enough of the watery component of tears. In the other, the oily outer layer of the tear film is deficient, usually because the tiny meibomian glands along the eyelid margins are blocked or dysfunctional. This second type, called evaporative dry eye, is actually the more common form and is closely tied to meibomian gland dysfunction (MGD). Many people have a mix of both. A treatment that addresses oil-layer problems will not do much for someone who is tear-deficient, and vice versa. That is why eye doctors increasingly try to figure out which subtype you have before recommending a plan.
Point-of-care diagnostic kits can now measure tear osmolarity (how concentrated your tears are) and detect inflammatory markers like MMP-9 on the eye’s surface, helping clinicians pinpoint whether inflammation or gland dysfunction is driving the problem.1PubMed. Tear Film-Based Diagnostics and Emerging Tissue Engineering Approaches in Personalized Dry Eye Disease Management Getting a proper evaluation matters because a blanket recommendation of “just use eye drops” misses the mark for a large number of dry eye sufferers.
Artificial Tears as a Starting Point
For most people with mild dry eye, over-the-counter artificial tears are the first thing to try. They come in two broad categories: preserved and preservative-free. The difference is more than marketing. Preservatives like benzalkonium chloride keep the bottle sterile but can damage the surface cells of the cornea with frequent use. A lab study comparing preservative-free tear solutions to those containing benzalkonium chloride found that under heavy dosing, the preservative-free solutions caused significantly less damage to corneal surface cells.2JAMA Ophthalmology. Preservative-Free Artificial Tear Preparations: Assessment of Corneal Epithelial Toxic Effects A more recent clinical study confirmed this in actual dry eye patients, showing that preservative-free drops outperformed preserved drops in both symptom scores and measurable corneal epithelial thickness, even when the preserved formulation used a milder preservative.3PubMed Central. Effect of Preserved Versus Preservative-Free Artificial Tears on the Corneal Epithelial Thickness Mapping by MS-39 in Dry Eye Patients
If you use artificial tears once or twice a day, the preservative issue is minor. But if you find yourself reaching for them four or more times daily, switching to preservative-free single-use vials is worth the extra cost. That advice is especially relevant for contact lens wearers or anyone on multiple eye drops for other conditions like glaucoma, since preservative exposure adds up across products.
Treating Meibomian Gland Dysfunction
Because evaporative dry eye driven by MGD is so common, a huge portion of treatment revolves around getting those oil glands working again. The simplest approach is a warm compress held against closed eyelids for five to ten minutes, followed by gentle lid massage to express the thickened oil. It sounds low-tech, and it is, but consistency is the challenge. Many people do not do it often enough or long enough for it to work.
For people who struggle with daily warm compresses, in-office devices that deliver sustained heat and gentle pressure to the eyelids have become popular. The best studied of these is vectored thermal pulsation therapy (sold as LipiFlow), which applies controlled heat to the inner eyelid while simultaneously pulsing pressure to unclog the glands. A meta-analysis of randomized trials found that thermal pulsation produced greater improvements in gland function, tear stability, and symptom scores compared to warm compresses at both one month and three months.4Cornea. Efficacy of Vectored Thermal Pulsation and Warm Compress Treatments in Meibomian Gland Dysfunction: A Meta-Analysis of Randomized Controlled Trials A separate trial found that a single LipiFlow session was similar in effectiveness to doing warm compresses twice daily for twelve weeks, suggesting the device may be a practical shortcut for people who will not keep up with the at-home routine.5PubMed Central. Clinical Trial of Thermal Pulsation (LipiFlow) in Meibomian Gland Dysfunction With Preteatment Meibography
Across about twenty studies evaluating various heat-and-pressure devices, roughly 95% reported improved symptoms and improved gland function, with adverse events mainly limited to temporary discomfort.6PubMed Central. Eyelid Warming Devices: Safety, Efficacy, and Place in Therapy The main downside is cost. LipiFlow sessions typically run several hundred dollars per treatment and are rarely covered by insurance. For moderate to severe MGD, many clinicians consider them a worthwhile step up when basic lid hygiene is not enough.
Prescription Anti-Inflammatory Drops
Dry eye disease involves a self-reinforcing cycle of inflammation: a compromised tear film irritates the eye’s surface, the irritation triggers immune cells, and the inflammation further damages the tear-producing structures. Breaking that cycle is the logic behind prescription anti-inflammatory eye drops, which are usually prescribed for moderate to severe cases that do not respond well to artificial tears and lid care alone.
Cyclosporine ophthalmic emulsion (best known by the brand name Restasis, with a newer nanomicellar formulation called Cequa) works by suppressing the local immune response on the eye’s surface. Randomized controlled trials have consistently shown that cyclosporine outperforms vehicle drops in reducing corneal staining, a sign of surface damage, and in increasing tear production as measured by Schirmer scores.7PubMed Central. Cyclosporine ophthalmic emulsions for the treatment of dry eye: a review of the clinical evidence It also has a unique ability to increase goblet cell density on the eye’s surface, which helps restore the mucin layer of the tear film.8PubMed Central. A Review of the Mechanism of Action of Cyclosporine A: The Role of Cyclosporine A in Dry Eye Disease and Recent Formulation Developments The catch is patience. Cyclosporine drops can take several weeks to months before you notice a real difference, and many people experience stinging upon instillation, especially early on.
Lifitegrast (Xiidra) is a newer option that works differently: it blocks the interaction between certain immune cell proteins, preventing T cells from activating and releasing inflammatory mediators.9PubMed Central. Lifitegrast: A novel drug for treatment of dry eye disease In clinical trials, lifitegrast reduced both signs and symptoms of dry eye compared to placebo. It tends to work faster than cyclosporine, with some patients noticing improvement within a couple of weeks, though it can leave a taste disturbance (dysgeusia) that some people find annoying. Your eye doctor may choose one over the other based on your symptoms, insurance formulary, or how you tolerate each.
Short-Term Steroid Drops
When dry eye flares are particularly severe or when a patient needs faster relief while waiting for cyclosporine or lifitegrast to kick in, eye doctors sometimes prescribe a short pulse of topical corticosteroid drops. A Cochrane systematic review found that topical corticosteroids probably provide small to moderate symptom relief beyond what lubricants alone offer, and may also give additional benefit beyond cyclosporine.10PubMed Central. Topical corticosteroids for dry eye A study of pulsed hydrocortisone drops in patients with Sjögren syndrome-related dry eye found that the treatment improved both signs and symptoms without raising intraocular pressure, a common worry with steroids.11PubMed. Short-term results of a pulsed therapy with hydrocortisone eye drops to treat moderate to severe dry eye in primary Sjögren syndrome patients
Steroid drops are not meant for long-term use. Even low-potency formulations carry the risk of elevated eye pressure and cataract formation if used for extended periods. They work best as a bridge therapy or a short burst to get acute inflammation under control before transitioning to a safer maintenance option.
Omega-3 Fatty Acid Supplements
Omega-3 fatty acids, from fish oil or flaxseed oil, have been studied extensively for dry eye. The idea is that their anti-inflammatory properties could calm the chronic low-grade inflammation that perpetuates the condition. A systematic review and meta-analysis of randomized controlled trials found that omega-3 supplementation produced significant improvements in dry eye symptoms, tear stability, tear production, and corneal staining compared to placebo.12PubMed Central. Efficacy of Omega-3 Intake in Managing Dry Eye Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials Individual trials have reported dramatic numbers. One found that tear stability improved by about 71% in the omega-3 group compared to roughly 3% in the placebo group over a short treatment period.13Ophthalmology. Short-Term Consumption of Oral Omega-3 Fatty Acid Supplements on Dry Eye Syndrome Another randomized trial reported that about 65% of patients on omega-3s had significant symptom improvement at three months, compared to a third in the placebo group.14PubMed Central. A randomized controlled trial of omega-3 fatty acids in dry eye syndrome
The picture is not entirely clean, though. A large NIH-sponsored trial called DREAM found no significant difference between omega-3 supplements and olive oil placebo after a year, muddying the waters. Many researchers argue that the DREAM trial’s choice of olive oil as a placebo was problematic because olive oil itself has anti-inflammatory properties. The overall weight of the meta-analytic evidence still leans in favor of omega-3s as a helpful add-on, particularly for people with mild to moderate symptoms who want to try a low-risk supplement before moving to prescription options. The typical studied doses combine EPA and DHA totaling around 1,000 to 2,000 milligrams per day.
Newer Treatments Worth Knowing About
The dry eye treatment landscape has expanded meaningfully in recent years. Two additions stand out.
Varenicline nasal spray (Tyrvaya) takes a completely different approach. Instead of putting something on the eye, you spray it in the nose. It stimulates a nerve pathway that triggers your own natural tear production. In a phase 3 randomized trial, about 47 to 49% of patients receiving the spray achieved a clinically meaningful increase in tear production, compared to about 28% with placebo.15PubMed. Efficacy and Safety of OC-01 (Varenicline Solution) Nasal Spray on Signs and Symptoms of Dry Eye Disease: The ONSET-2 Phase 3 Randomized Trial Its appeal is that it promotes your own tears, with their full natural composition, rather than adding a substitute from a bottle. The most common side effect is sneezing, which is transient but surprises people who are not expecting it.
Perfluorohexyloctane ophthalmic solution (Miebo) is the first eye drop specifically designed to target the lipid layer of the tear film. It forms a thin layer on the tear surface that mimics the function of the natural oil layer, slowing evaporation.16PubMed. Perfluorohexyloctane Ophthalmic Solution: A Review in Dry Eye Disease Lab testing showed it significantly inhibited evaporation from a saline surface, supporting the idea that it can functionally substitute for a deficient native lipid layer.17Current Therapeutic Research. In Vitro Inhibition of Evaporation with Perfluorohexyloctane, an Eye Drop for Dry Eye Disease This is particularly relevant for people with evaporative dry eye driven by MGD, and it is water-free, so it does not blur vision the way some thicker artificial tears can.
Intense Pulsed Light Therapy
Intense pulsed light (IPL), originally developed for skin conditions like rosacea, has found a growing role in dry eye treatment, especially for MGD. The light pulses warm and liquefy the thickened oil in clogged meibomian glands while also reducing inflammation and abnormal blood vessel growth along the eyelid margins. A three-year retrospective study found that about 87% of treated patients showed improvement in tear stability, and 93% reported satisfaction with their symptom relief, with adverse events (mainly temporary redness or mild swelling) occurring in about 13% of patients.18PubMed Central. Intense pulsed light treatment for dry eye disease due to meibomian gland dysfunction; a 3-year retrospective study Another study found significant improvements in lid margin health, oil flow, and tear breakup time after an average of four sessions.19PubMed. Outcomes of intense pulsed light therapy for treatment of evaporative dry eye disease
There is evidence that IPL may also reduce pro-inflammatory markers on the ocular surface. The benefits tend to fade after about six months, so maintenance sessions are usually needed.20PubMed Central. Pulsed Light Therapy in the Management of Dry Eye Disease: Current Perspectives Researchers generally consider IPL an adjunct to standard care rather than a first-line treatment, best suited for moderate to severe MGD that has not responded adequately to warm compresses and lid hygiene alone. Like thermal pulsation, cost is a barrier since IPL for dry eye is typically not covered by insurance.
Punctal Plugs
If your eyes do not produce enough tears, another strategy is to keep whatever tears you do make on the eye’s surface longer. Punctal plugs are tiny silicone inserts placed into the tear drainage ducts (puncta) at the inner corner of your eyelids, slowing the rate at which tears drain away. A study of fifty patients found that six months after plug placement, 86% were symptom-free and 76% had stopped using daily lubricants.21PubMed. Efficacy and tolerability outcomes after punctal occlusion with silicone plugs in dry eye syndrome
Plugs are generally well tolerated, but they do fall out. In that same study, the estimated probability of a plug still being in place after six months was about 63%, and upper punctal plugs were far more likely to be lost than lower ones. Some clinicians start with temporary collagen plugs that dissolve on their own in a few months, which acts as a trial run: if your symptoms improve, you graduate to the longer-lasting silicone version. Punctal plugs are not ideal for everyone. In patients with significant ocular surface inflammation, trapping inflammatory tears on the eye can actually make things worse, so plugs work best once inflammation has been brought under control with other treatments.
Autologous Serum Drops and Scleral Lenses
For severe, treatment-resistant dry eye, two options sit further down the treatment ladder. Autologous serum eye drops are made from your own blood. After a blood draw, the serum is separated, diluted, and dispensed into single-use vials. Serum contains growth factors, vitamins, and proteins that closely mimic the natural tear film, providing lubrication and promoting healing of the corneal surface.22PubMed Central. Autologous serum eye drops in dry eye disease: Preferred practice pattern guidelines They have been used successfully for decades in cases of dry eye that do not respond to conventional therapy, including artificial tears and cyclosporine.23Cochrane Database of Systematic Reviews. Autologous serum eye drops for dry eye The downsides are logistical: they require a blood draw, compounding by a pharmacy, refrigerated storage, and a limited shelf life.
Scleral lenses are large-diameter rigid gas-permeable contact lenses that vault over the entire cornea, resting on the white of the eye (the sclera). The fluid reservoir trapped between the lens and the cornea essentially bathes the eye in a constant layer of tears throughout the day. They prevent tear evaporation and contact lens dehydration while also correcting vision.24PubMed Central. Scleral Lenses for Managing Dry Eye Disease in the Absence of Corneal Irregularities: What Is the Current Evidence? Scleral lenses require a specialist fitting and take some practice to insert and remove, but for people with severe dry eye who have failed other therapies, they can be transformative in terms of comfort and daily function.
Screen Time, Blinking, and Environmental Factors
Treatment is only half the equation. For a lot of people, especially those with mild to moderate symptoms, environmental and behavioral adjustments make a real difference. Screen use is a major aggravator. When you stare at a computer, tablet, or phone, your blink rate drops and a larger proportion of your blinks become incomplete, meaning the upper eyelid does not fully sweep across the cornea. This allows the tear film to thin and break apart faster.25PubMed Central. The Relationship Between Dry Eye Disease and Digital Screen Use Incomplete blinks may actually matter more than reduced blink rate, because tear film stability can sometimes hold up even with fewer blinks, as long as those blinks are full ones.26BMJ Open Ophthalmology. Digital eye strain: prevalence, measurement and amelioration
Practical steps include taking regular breaks from screens (the often-cited “20-20-20 rule,” where you look at something 20 feet away for 20 seconds every 20 minutes), consciously blinking fully during screen tasks, positioning your monitor slightly below eye level so you are not staring wide-eyed, and using a humidifier in dry indoor environments. None of these will cure established dry eye disease, but for screen-heavy workers whose symptoms are primarily related to prolonged digital device use, they can meaningfully reduce the burden.
Medications That Make Dry Eye Worse
Before layering on treatments, it is worth checking whether something you are already taking is contributing to the problem. Several common medication classes are known to worsen dry eye. Data from the large DREAM study found that antihistamine users had worse tear stability and higher symptom scores compared to non-users.27PubMed Central. Association between systemic medication use and severity of dry eye signs and symptoms in the DRy eye assessment and management (DREAM) study Other classes frequently linked to dry eye include certain antidepressants, beta-blockers, diuretics, and isotretinoin (the acne drug). If you are on one of these and struggling with dry eye, a conversation with your prescribing doctor about alternatives or dose adjustments can sometimes help more than adding another eye drop.
Hormonal Factors and Who Gets Dry Eye
Dry eye is not distributed evenly across the population. It is more common in women, and prevalence climbs around menopause and beyond. Sex hormones, particularly estrogens and androgens, influence the production of all three layers of the tear film: watery, oily, and mucin. Shifts in hormone levels during perimenopause and menopause alter the balance of these components, contributing to ocular surface dryness.28PubMed Central. Dry Eye Syndrome in Menopause and Perimenopausal Age Group Hormonal factors do not change the treatment toolkit, but they help explain why some people develop dry eye seemingly out of nowhere in midlife and why it often requires ongoing management rather than a one-time fix.
Dry Eye After LASIK and Other Surgeries
Dry eye is the most common complication after LASIK, largely because creating the corneal flap cuts through the sensory nerves that help regulate tear production. Most post-LASIK dry eye resolves within several months as corneal nerves regenerate, but for some people it persists longer. Research into nerve growth factor (NGF) drops has shown that NGF treatment significantly accelerated the recovery of corneal nerve density and corneal sensitivity after LASIK compared to standard lubricant treatment.29PubMed. The effect of nerve growth factor on corneal nerve regeneration and dry eye after LASIK NGF drops are not yet widely available as a standard clinical option, but they represent a promising direction for surgery-related dry eye that does not respond to conventional management. If you are considering LASIK and already have dry eye symptoms, having your ocular surface optimized beforehand can reduce the severity of post-operative dryness.
The Mental Health Connection
Chronic dry eye takes a real toll on quality of life, and the connection runs deeper than simple annoyance. Growing evidence points to a bidirectional relationship between dry eye disease and psychiatric conditions, particularly depression, anxiety, and sleep disturbances.30PubMed Central. Dry Eye Disease and Psychiatric Disorders: Neuroimmune Mechanisms and Therapeutic Perspectives The constant irritation and visual disruption of dry eye can erode mood and concentration, while depression and anxiety may themselves worsen the condition through shared inflammatory pathways and altered pain perception. This bidirectional link is worth keeping in mind because it means that in severe cases, treating the mental health side of the equation may improve the eye symptoms, and effectively managing the dry eye can help alleviate associated mood disturbances. If dry eye is interfering with your sleep, your ability to read, or your overall sense of well-being, communicating that to your eye doctor can help them understand the severity and escalate treatment appropriately.